Today, because of advances in treatment, more than eight out of 10 children treated for cancer survive at least five years, most into adulthood. However, the same treatments that help these children survive can also cause immediate and late-term health effects, even in the mouth.
Texas A&M researchers show why targeting a gene called RASSF1A can reduce the deleterious effects of malignant tumors during chemotherapy
An enzyme overexpressed in cancer can be both a marker of the disease and a way to target the cancerous tumor
The next major step in treating or even curing epilepsy may come from cancer drugs
How a Texas A&M researcher is working to improve quality of life for cancer survivors
Collaboration between Texas A&M researchers and architecture firm promises evidence-based designs for cancer centers
Beating cancer is a team effort